DURECT Corporation Reports First Quarter 2023 Financial Results and Business UpdatePRNewsWire • 05/08/23
DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8PRNewsWire • 05/01/23
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor ConferencePRNewsWire • 04/25/23
DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated HepatitisPRNewsWire • 04/10/23
DURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare ConferencePRNewsWire • 03/09/23
DURECT Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and AHFIRM Trial UpdatePRNewsWire • 03/07/23
DURECT Corporation to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 7PRNewsWire • 02/28/23
DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and WarrantsPRNewsWire • 02/03/23
DURECT Corporation Reports Third Quarter 2022 Financial Results and Update of ProgramsPRNewsWire • 11/02/22
DURECT Corporation to Announce Third Quarter 2022 Financial Results and Provide Business Update on November 2PRNewsWire • 10/26/22
DURECT Corporation to Present at the H.C. Wainwright Global Investment ConferencePRNewsWire • 09/06/22
DURECT Corporation's (DRRX) CEO Jim Brown on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/06/22
DURECT Corporation Reports Second Quarter 2022 Financial Results and Update of ProgramsPRNewsWire • 08/04/22
DURECT Corporation to Announce Second Quarter 2022 Financial Results and Provide Business Update on August 4PRNewsWire • 07/27/22